The AI and Web3 narrative is moving at lightning speed. ⚡🤖Projects with real utility and on-chain revenue are separating themselves from the noise.Are you bags
$GOAI is gaining momentum! Shares hit $0.5297, up 4.05%, with bullish sentiment scoring 82. Market cap stands at $20.63M.
Buyers are showing interest - could this be the start of a bigger move?
12% is the first thing I'd check too, but the real question with $GOAI is what happens to that rate if the deal slips. cost of capital homework beats a rushed trade any night.
#BBNaija
$TSLA $COIN $SOFI
i caught myself comparing the 12% on this $1.88 Million $GOAI note to the savings rates i quote at the credit union window, which is a silly comparison but my brain went there first.
for Eva Live the rate is the line i keep rereading. mrs. gable taught me to look at what money costs before what it buys, so that's where my sticky note starts tonight.
no trade from me. just homework for the thesis.
Convertible notes keep dilution predictable, which is refreshing for a small cap. Curious to see the actual cash line on the next filing for $GOAI.
#VIVANT
$TSLA $ORCL $ASTS
$GOAI getting up to $1.88 Million from one secured note, with no big public raise attached.
A single convertible note means the share count stays easier to track, and that's the first thing I look at in any filing. I like it when a small company lines up funding this way.
Up to $1.88 million also means the full amount may not get funded, so I'll check the cash line when it lands. Raj says I read these too slowly anyway.
$GOAI has Eva Live raising up to $1.88 Million with Dune Equity as the investor.
Tobias asked me this morning what I look at first in a junior's news, and I told him the course. A named backer on the filing gives me that much to work with, the way a clear flight line does at 4 mph winds.
The amount is capped at up to $1.88 Million, which I'm fine with.
I keep coming back to the manufacturing angle with $VICP They're exploring a 120,000 sq. ft. facility in Puerto Rico, with about 50,000 sq. ft. of cleanroom space and another 70,000 sq. ft. for warehousing and distribution
That's a substantial footprint if the acquisition happens. Combine that with their existing Stateline operation, and you can see why management is thinking beyond basic drug distribution
what's the first number you check in a note? mine is the conversion price, even before the $1.88 Million headline.
$GOAI's Dune note converts at a fixed $2.50 per share, simple enough to write on a sticky note before i even open the app. it only goes market-based if there's a default, so i know what i'm checking against.
kinda glad it's written down up front.
A $2M deal for NitroMist might sound small compared to big pharma acquisitions, but the strategy behind it is what stands out to me
$VICP is looking to bring an FDA-approved nitroglycerin spray back to market while building on Stateline's existing healthcare distribution network. Owning a product and having a way to sell it could be a useful combination. The real milestone will be completing the acquisition and relaunch
One thing I find interesting about $VICP is how much its business model has changed in just a few months. The September merger with Stateline brought roughly 400 healthcare accounts, and the company now has a distribution model reaching all 50 states. That's a pretty big shift for a biotech that previously had no meaningful product revenue. The next thing worth watching is whether that reach translates into actual sales growth
My first reaction to Additional GOAI shares from the CEO was to do nothing, and I'm fine with that. $GOAI had two modest buys inside one week, which is the pattern I find easiest to live with.
Owen's coach says the best shifts are the ones nobody remembers. Insider buying works that way for me too. One big jump makes me want to react. Two small purchases in a row give me something to put on the index card and leave alone.
He directly owns 23,266,225 shares after this one. I'll read the next Form 4 whenever it shows up, over Sunday coffee.
Sat in the truck at 0600 waiting for the wind to drop under 8 mph when this came through. $GOAI has up to $1.88 Million lined up with Dune Equity, aimed at liquidity and funding flexibility.
Static was asleep on my flight logs while I read it. Eva Live gets some room to keep its AI work moving, and I like seeing a small company get that.
In 5 hours I'm hosting the largest free class I've ever done.
If you find yourself taking retest and getting wrecked.
Your read isn’t wrong.
You just haven’t been taught this one trick that will change everything.
See you at 7pm EST.
https://t.co/ZlPL77rtAC
Been digging into $VICP, and there's actually a pretty interesting business taking shape here. The Stateline merger brought roughly 400 healthcare accounts and distribution reach across all 50 states. Now they're working on adding NitroMist through a $2M acquisition agreement. That's a real shift from being just another early-stage biotech. If management can turn that infrastructure into growing sales, this could get interesting fast
1.88M isn't huge but it's real money to actually build with. Curious what Eva Live does with it - the crane drawing is the best part though. $GOAI
#VIVANT
$VICP $NFLX $META
Would you call up to $1.88 Million a lot of runway? Wren asked me what raising money means, and I told him it's money to build with.
I saw $GOAI come across my feed and it made me smile a little. On my Saturday drives I love the moment a bare lot gets a frame on it, and a company getting funding feels like that same moment to me.
Eva Live is raising up to that amount, and I'll be watching what gets built with it. Wren says he'd draw it with a crane on top.
Who is the $1.88 Million for $GOAI actually for? Probably whoever has been waiting on money to keep building.
The agreements were signed and effective Oct 02 2026, so nothing is hanging in the air. I like that. After a few vendor pilots where everything dragged on for weeks, a deal that is simply done on day one feels good to me.
Eva Live gets to keep working on its AI products with that in place, and I'll be curious what shows up next.
VICP Could Be Building Something Bigger Than a Typical OTC BiotechVicapsys completed its Stateline merger, gaining ~400 healthcare accounts and distribution reach across all 50 states. It also signed a $2M deal for FDA-approved NitroMist, is exploring a 120,000 sq. ft. manufacturing facility, and has a tribal 8(a) partnership opening federal contracting opportunities.Add its VICAPSYN diabetes cell-therapy program, and there's a compelling expansion story here. Execution will be key
$GOAI A team of three can't own the fleet, and I circled that before the $38.8 Billion precision farming projection.
Eva Live says it will scale through agricultural service providers and technology partners instead of owning every drone customers fly. I'm glad it's said that plainly. Owning the fleet takes heavy capital, so the lighter setup actually fits who they are.
Next I want to see which service providers sign on first.
I expected a side project behind that $38.8 Billion, and then I saw the defense drone work carried over.
I'm glad $GOAI is reusing tech it already developed. EvaFarmSight draws on autonomous drone concepts and machine vision from Eva Defense, so a good part of the groundwork exists already.
For someone who reads the cash flow before anything else, that makes me feel better about it. Less new money should go out the door for a new project. I'll watch the next filing to see if the spending shows it.
The institutional narrative around $GOAI is undeniable
The presence of Vanguard, BlackRock, and Citadel Advisors on the list of major holders validates the long-term outlook
Combine this institutional accumulation with a Q4 net profit of $8.1M and a Binance analyst consensus 12-month target of $7.00, and the setup is compelling
Easiest trade offer of 2026?